Q: I have noticed more of ROP’s applications in use by in the medical world. It continues to remains on RBC’s top global ideas for 2020. Is it over-valued right now? Does it have the balance sheet and cash flow from existing operations to continue its acquisition strategy?
The share price worries me. Should it? Or does ROP deserve its rich price due to its growth potential? If you would buy, what would be reasonable entry price (or would you be patient and wait for the next market dip?)
The share price worries me. Should it? Or does ROP deserve its rich price due to its growth potential? If you would buy, what would be reasonable entry price (or would you be patient and wait for the next market dip?)